PK

Pavani Kathi

Active Director Director DIN 08723013
DIN 08723013 First appointment Mar 2020 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2020
Shareholding value •••• Premium profile

About Pavani Kathi

Data last updated:

Pavani Kathi is a Director at Erotas Pharmaceuticals Private Limited (since 2020). The company operates in Pharma. Erotas Pharmaceuticals Private Limited reported revenue of ₹40.5 Lakh (FY 2025).

DIN 08723013
Primary Designation Director
Industry Pharma
First Appointment 13 Mar 2020
Oldest Company Age 6 yrs
Largest company Erotas Pharmaceuticals Private Limited · ₹40.5 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director13 Mar 20202020₹40.5 Lakh (FY 2025)Active

Board colleagues of Pavani Kathi

NameDINCompanyDesignation
Ramesh Gamini08722982Erotas Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Erotas Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Pavani Kathi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pavani Kathi

Pavani Kathi currently holds 1 directorship: Erotas Pharmaceuticals Private Limited (Director, since 13 Mar 2020, revenue ₹40.5 Lakh (FY 2025)).

Pavani Kathi was first appointed on 13 Mar 2020 as Director at Erotas Pharmaceuticals Private Limited.

The current boards of Pavani Kathi's companies include Ramesh Gamini (Erotas Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available